References
Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217–1239.
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al.: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204–210.
Doherty LS, Kiely JL, Swan V, McNicholas WT: Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127:2076–2084.
Stepnowsky CJ Jr, Marler MR, Ancoli-Israel S: Determinants of nasal CPAP compliance. Sleep Med 2002, 3:239–247.
Young T, Skatrud J, Peppard PE: Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291:2013–2016.
Guilleminault C, Lee JH, Chan A: Pediatric obstructive sleep apnea syndrome. Arch Pediatr Adolesc Med 2005, 159:775–785.
Rights and permissions
About this article
Cite this article
Thorpy, M. Obstructive sleep apnea syndrome is a risk factor for stroke. Curr Neurol Neurosci Rep 6, 147–148 (2006). https://doi.org/10.1007/s11910-996-0037-4
Issue Date:
DOI: https://doi.org/10.1007/s11910-996-0037-4